Global Bioresorbable
Vascular Scaffold Market, by Product Type (Synthetic and Biological), by
Material (Metal based BVS, Polymer based BVS), by Application (Coronary Artery
Stents, Peripheral Artery Stents, and Others), by End User (Hospitals,
Ambulatory Surgical Centers, Cardiac Centers, and Others), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was
valued at US$ 147.0 million in 2017, and is projected to exhibit a CAGR of
12.5% over the forecast period (2018 – 2026).
Launch of novel bioresorbable
vascular scaffold by market players is expected to augment the market growth
Key players in the market are focused on launching novel bioresorbable vascular
scaffold in order to reduce the risk of coronary artery inflammation, which
leads to thrombosis and stent restenosis and address critical unmet needs of
patients. For instance, in May 2017, Medtronic launched 4.5 mm and 5 mm sizes
Resolute Onyx, drug-eluting stent, in U.S. following FDA approval, which was
the first drug-eluting stent. Similarly, in September 2012, Abbott launched
Absorb, a bioresorbable vascular scaffold disappearing stent, across Europe and
parts of Asia Pacific and Latin America. In May 2017 Medtronic, Plc. received
U.S. Food and Drug Administration (FDA) approval for its Resolute Onyx, a 2.0mm
size zotarolimus-eluting stent with unique continuous sinusoid technology.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2471
Browse 22 Market Data Tables and
26 Figures spread through 158 Pages and in-depth TOC on ‘Bioresorbable Vascular
Scaffold Market’- Global Forecast to 2026, Product Type (Synthetic,
Biological), by Material (Metal based BVS, Polymer Based BVS), by application
(Coronary Artery Stents, Peripheral Artery Stents, Others), by End User
(Hospitals, Ambulatory Surgical Centers, and Cardiac Centers, Others), and by
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa)
Key players in the market are
focused on adopting strategies such as mergers and acquisitions to enhance its
product portfolio. For instance, in February 2016, Maquet Medical Systems, a
Getinge Group Company, announced plans to enter into partnership with
BIOTRONIK, a Germany-based manufacturer of cardiovascular and endovascular
medical devices, to distribute BIOTRONIK’s peripheral vascular devices in the
U.S.
Key Takeaways of the Bioresorbable
Vascular Scaffold Market:
The global bioresorbable vascular
scaffold market is expected to exhibit a CAGR of 12.5% over the forecast
period, owing to the increasing prevalence of cardiopulmonary conditions,
cancer, and renal diseases
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/bioresorbable-vascular-scaffold-market-2471
Among product type, the synthetic
segment held a dominant position in the bioresorbable vascular scaffold market
in 2018, owing to higher adoption of synthetic bioresorbable vascular scaffold
over other treatment options such as antibiotic treatment and nutrition
Among material type, polymer
based segment held a dominant position in the bioresorbable vascular scaffold
market in 2018, due to its comparative advantages over metallic type.
Among application type, coronary
artery stents held a dominant position in the bioresorbable vascular scaffold
market in 2018, owing to high prevalence of cardiovascular diseases across the
world
Key players operating in the
global bioresorbable vascular scaffold market include Abbott, Cook Medical,
Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG
(Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun
Melsungen AG, and Terumo Corporation among others
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2471
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment